Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-29 @ 12:15 AM
Study NCT ID:
NCT00918203
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2009-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization: